93 related articles for article (PubMed ID: 11835199)
1. Targeting of liposomes to melanoma cells with high levels of ICAM-1 expression through adhesive peptides from immunoglobulin domains.
Jaafari MR; Foldvari M
J Pharm Sci; 2002 Feb; 91(2):396-404. PubMed ID: 11835199
[TBL] [Abstract][Full Text] [Related]
2. P0 protein mediated targeting of liposomes to melanoma cells with high level of ICAM-1 expression.
Jaafari MR; Foldvari M
J Drug Target; 1999; 7(2):101-12. PubMed ID: 10617296
[TBL] [Abstract][Full Text] [Related]
3. Targeting of liposomes to human keratinocytes through adhesive peptides from immunoglobulin domains in the presence of IFN-gamma.
Jaafari MR; Foldvari M
Drug Deliv; 2002; 9(1):1-9. PubMed ID: 11839203
[TBL] [Abstract][Full Text] [Related]
4. Intracellular delivery of drugs by liposomes containing P0 glycoprotein from peripheral nerve myelin into human M21 melanoma cells.
Foldvari M; Mezei C; Mezei M
J Pharm Sci; 1991 Nov; 80(11):1020-8. PubMed ID: 1726112
[TBL] [Abstract][Full Text] [Related]
5. Targeting liposomes through immunoglobulin superfamily domains: P0 protein as a model.
Foldvari M; Jaafari MR; Mezei M; Mezei C
Drug Deliv; 1998; 5(3):183-95. PubMed ID: 19569984
[TBL] [Abstract][Full Text] [Related]
6. ICAM-2 and a peptide from its binding domain are efficient activators of leukocyte adhesion and integrin affinity.
Kotovuori A; Pessa-Morikawa T; Kotovuori P; Nortamo P; Gahmberg CG
J Immunol; 1999 Jun; 162(11):6613-20. PubMed ID: 10352278
[TBL] [Abstract][Full Text] [Related]
7. The dependence for leukocyte function-associated antigen-1/ICAM-1 interactions in T cell activation cannot be overcome by expression of high density TCR ligand.
Abraham C; Griffith J; Miller J
J Immunol; 1999 Apr; 162(8):4399-405. PubMed ID: 10201975
[TBL] [Abstract][Full Text] [Related]
8. Levamisole effects on major histocompatibility complex and adhesion molecule expression and on myeloid cell adhesion to human colon tumor cell lines.
Kimball ES; Fisher MC
J Natl Cancer Inst; 1996 Jan; 88(2):109-16. PubMed ID: 8537971
[TBL] [Abstract][Full Text] [Related]
9. Human neural cell adhesion molecule L1 and rat homologue NILE are ligands for integrin alpha v beta 3.
Montgomery AM; Becker JC; Siu CH; Lemmon VP; Cheresh DA; Pancook JD; Zhao X; Reisfeld RA
J Cell Biol; 1996 Feb; 132(3):475-85. PubMed ID: 8636223
[TBL] [Abstract][Full Text] [Related]
10. Competition between intercellular adhesion molecule-1 and a small-molecule antagonist for a common binding site on the alphal subunit of lymphocyte function-associated antigen-1.
Keating SM; Clark KR; Stefanich LD; Arellano F; Edwards CP; Bodary SC; Spencer SA; Gadek TR; Marsters JC; Beresini MH
Protein Sci; 2006 Feb; 15(2):290-303. PubMed ID: 16384997
[TBL] [Abstract][Full Text] [Related]
11. ICAM- melanoma cells are relatively resistant to CD3-mediated T-cell lysis.
Braakman E; Goedegebuure PS; Vreugdenhil RJ; Segal DM; Shaw S; Bolhuis RL
Int J Cancer; 1990 Sep; 46(3):475-80. PubMed ID: 1975566
[TBL] [Abstract][Full Text] [Related]
12. The effect of acidic pH on the inhibitory efficacy of peptides against the interaction ICAM-1/LFA-1 studied by surface plasmon resonance (SPR).
Wu SH; Núnez D; Hu SY; Domingo MP; Chen YC; Wei PK; Pardo J; Gálvez EM; Chiou A
Biosens Bioelectron; 2014 Jun; 56():159-66. PubMed ID: 24487103
[TBL] [Abstract][Full Text] [Related]
13. Lymphocyte leukocyte function-associated antigen 1 interacting with target cell intercellular adhesion molecule 1 co-activates cytolysis triggered via CD16 or the receptor involved in major histocompatibility antigen-unrestricted lysis.
Goedegebuure PS; Braakman E; Segal DM; Vreugdenhil RJ; Bolhuis RL
Int Immunol; 1990; 2(12):1213-20. PubMed ID: 1982501
[TBL] [Abstract][Full Text] [Related]
14. Identification of the binding site in intercellular adhesion molecule 1 for its receptor, leukocyte function-associated antigen 1.
Fisher KL; Lu J; Riddle L; Kim KJ; Presta LG; Bodary SC
Mol Biol Cell; 1997 Mar; 8(3):501-15. PubMed ID: 9188101
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the metastasis of murine malignant melanoma by synthetic polymeric peptides containing core sequences of cell-adhesive molecules.
Saiki I; Iida J; Murata J; Ogawa R; Nishi N; Sugimura K; Tokura S; Azuma I
Cancer Res; 1989 Jul; 49(14):3815-22. PubMed ID: 2736523
[TBL] [Abstract][Full Text] [Related]
16. Novel RGD lipopeptides for the targeting of liposomes to integrin-expressing endothelial and melanoma cells.
Hölig P; Bach M; Völkel T; Nahde T; Hoffmann S; Müller R; Kontermann RE
Protein Eng Des Sel; 2004 May; 17(5):433-41. PubMed ID: 15235124
[TBL] [Abstract][Full Text] [Related]
17. The role of LFA-1 (CD11a/CD18) cytoplasmic domains in binding to intercellular adhesion molecule-1 (CD54) and in postreceptor cell spreading.
Pyszniak AM; Carpenito C; Takei F
Exp Cell Res; 1997 May; 233(1):78-87. PubMed ID: 9184078
[TBL] [Abstract][Full Text] [Related]
18. A peptide derived from LFA-1 protein that modulates T-cell adhesion binds to soluble ICAM-1 protein.
Jois SD; Teruna TJ
J Biomol Struct Dyn; 2003 Apr; 20(5):635-44. PubMed ID: 12643766
[TBL] [Abstract][Full Text] [Related]
19. Critical amino acids in the lymphocyte function-associated antigen-1 I domain mediate intercellular adhesion molecule 3 binding and immune function.
van Kooyk Y; Binnerts ME; Edwards CP; Champe M; Berman PW; Figdor CG; Bodary SC
J Exp Med; 1996 Mar; 183(3):1247-52. PubMed ID: 8642267
[TBL] [Abstract][Full Text] [Related]
20. Differential expression and release of LFA-3 and ICAM-1 in human melanoma cell lines.
Scheibenbogen C; Keilholz U; Meuer S; Dengler T; Tilgen W; Hunstein W
Int J Cancer; 1993 May; 54(3):494-8. PubMed ID: 7685328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
